Published in J Intern Med on October 01, 1995
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid (2015) 2.67
Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. Cancer Genet (2012) 1.34
Pheochromocytoma in MEN 2A syndrome. Study of 54 patients. World J Surg (2008) 1.20
Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine. Am J Hum Genet (1997) 1.16
Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nat Rev Endocrinol (2011) 1.05
Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst (2013) 0.98
Spontaneous adrenal pheochromocytoma rupture complicated by intraperitoneal hemorrhage and shock. World J Emerg Surg (2011) 0.90
Paragangliomas/Pheochromocytomas: clinically oriented genetic testing. Int J Endocrinol (2014) 0.89
Multiple endocrine neoplasia type 2. Fam Cancer (2005) 0.88
Malignant pheochromocytomas and paragangliomas: a diagnostic challenge. Langenbecks Arch Surg (2011) 0.83
Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: implications for screening. J Surg Oncol (2013) 0.79
Medullary thyroid carcinoma: The third most common thyroid cancer reviewed. Oncol Lett (2010) 0.75
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int (2000) 4.85
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
[Recommendations and unanswered questions in the diagnosis and treatment of thyroid nodules. Opinion of the Thyroid Section of the German Society for Endocrinology]. Dtsch Med Wochenschr (2005) 2.45
Clonal rat parathyroid cell line expresses a parathyroid hormone-related peptide but not parathyroid hormone itself. Biochem Biophys Res Commun (1989) 2.15
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet (1994) 2.14
Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg (2000) 2.07
Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol (2000) 2.05
Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene (2010) 1.93
Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells. Cancer Res (2000) 1.90
Parathyroid glands: combination of (99m)Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology (2000) 1.80
Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg (1995) 1.78
Detection of RET proto-oncogene codon 634 mutations using mass spectrometry. J Mol Med (Berl) (1997) 1.77
Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients. Am J Surg Pathol (2001) 1.75
Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas. J Pathol (1998) 1.72
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet (2003) 1.69
How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis. Osteoporos Int (2010) 1.68
Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis. Calcif Tissue Int (2003) 1.65
Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med (1989) 1.64
Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN1). Exp Clin Endocrinol Diabetes (2000) 1.64
Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Intern Med (2005) 1.58
Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab (2002) 1.57
Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care. Bone (2011) 1.55
Myocardial calcification after orthotopic heart transplantation. J Heart Transplant (1988) 1.53
Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet (1994) 1.51
Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma? J Clin Endocrinol Metab (2005) 1.51
Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential. Histopathology (2008) 1.51
Parathyroid adenomas in the aortopulmonary window. Radiology (1996) 1.46
Characterization of adrenal masses using MR imaging with histopathologic correlation. AJR Am J Roentgenol (1999) 1.46
Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: results of a 3-year follow-up study. Clin Endocrinol (Oxf) (2000) 1.45
Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg (1998) 1.42
Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Drug Metab Dispos (1995) 1.39
A patient with evidence of two underlying diseases causing hypercalcaemia. Nephrol Dial Transplant (2001) 1.38
Use of an internal standard to measure pyridinoline and deoxypyridinoline in urine. Clin Chem (1994) 1.38
Hip fractures in Italy: 2000-2005 extension study. Osteoporos Int (2009) 1.36
Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int (2007) 1.33
Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab (1997) 1.31
The relationship of growth and adenylate cyclase activity in cultured thyroid cells: separate bioeffects of thyrotropin. Endocrinology (1983) 1.29
Antidepressant medications and osteoporosis. Bone (2012) 1.28
Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab (1997) 1.26
Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology (2006) 1.24
Liver resection of colorectal metastases in elderly patients. Br J Surg (2010) 1.21
Antibodies cytotoxic to bovine parathyroid cells in autoimmune hypoparathyroidism. Proc Natl Acad Sci U S A (1986) 1.21
Quantification of unconjugated metanephrines in human plasma without interference by acetaminophen. Clin Chem (2001) 1.20
Cardiological effects of catecholamine-secreting tumours. Eur J Clin Invest (1997) 1.18
Management of concomitant hepatic artery injury in patients with iatrogenic major bile duct injury after laparoscopic cholecystectomy. Br J Surg (2008) 1.18
Perioperative management of pheochromocytoma/paraganglioma: is there a state of the art? Horm Metab Res (2012) 1.17
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet (2000) 1.16
Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Arch Intern Med (2000) 1.16
Growth regulation of normal thyroids and thyroid tumors in man. Recent Results Cancer Res (1990) 1.16
Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N Engl J Med (1994) 1.15
Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab (2005) 1.15
Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. J Clin Endocrinol Metab (2001) 1.13
Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest (1994) 1.13
Surgical treatment of distant metastases in differentiated thyroid cancer: indication and results. Surgery (1986) 1.12
MHC class I molecule-restricted presentation of viral antigen in beta 2-microglobulin-deficient mice. J Immunol (1994) 1.11
Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med (1993) 1.11
Balloon kyphoplasty and vertebroplasty in the management of vertebral compression fractures. Osteoporos Int (2011) 1.11
Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes Chromosomes Cancer (1995) 1.10
Management of mycoses in surgical patients -- review of the literature. Eur J Med Res (2002) 1.10
Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol (2006) 1.08
Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties. J Clin Endocrinol Metab (2001) 1.08
E-cadherin: a differentiation marker in thyroid malignancies. Cancer Res (1993) 1.08
CD97: a dedifferentiation marker in human thyroid carcinomas. Cancer Res (1997) 1.07
Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab (1997) 1.07
The role of calcium and vitamin D in the management of osteoporosis. Bone (2007) 1.06
Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1. Cancer Res (1991) 1.06
The transplantation of parathyroid tissue in man: development, indications, technique, and results. Endocr Rev (1982) 1.06
Treatment of osteoporosis in men. Bone (2012) 1.06
Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Am J Surg Pathol (1997) 1.06
Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper. Osteoporos Int (2012) 1.05
Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med (1995) 1.05
Novel mutations and inactivation of both alleles of the APC gene in desmoid tumors. Hum Mol Genet (1995) 1.05
Bovine parathyroid cells: cultures maintained for more than 140 population doublings. Proc Natl Acad Sci U S A (1986) 1.04
Absent intestinal response to calciferols in hereditary resistance to 1,25-dihydroxyvitamin D: documentation and effective therapy with high dose intravenous calcium infusions. J Clin Endocrinol Metab (1988) 1.04
Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation. Oncogene (1999) 1.03
Endoscopic tube implantation for the palliation of malignant esophageal stenosis. Endoscopy (1990) 1.03
Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am J Hum Genet (1995) 1.03
Phorbol ester induced osteoclast-like differentiation of a novel human leukemic cell line (FLG 29.1). J Cell Biol (1992) 1.02
Sequence analysis of the mismatch repair gene hMSH6 in the germline of patients with familial and sporadic colorectal cancer. Int J Cancer (2000) 1.02
Biology of bone endothelial cells. Bone Miner (1990) 1.02
Vitamin D receptor as a candidate tumor-suppressor gene in severe hyperparathyroidism of uremia. J Clin Endocrinol Metab (2000) 1.01
Functional estrogen receptor beta in colon cancer cells. Biochem Biophys Res Commun (1999) 1.01
Relaxin influences growth, differentiation and cell-cell adhesion of human breast-cancer cells in culture. Int J Cancer (1994) 1.01
Sporadic hypercalcitoninemia: clinical and therapeutic consequences. Endocr Relat Cancer (2008) 1.01
[Incidence and socioeconomic burden of hip fractures in Italy: extension study 2003-2005]. Reumatismo (2010) 1.00
Regulation of CD97 protein in thyroid carcinoma. J Clin Endocrinol Metab (1999) 1.00
Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation. J Hepatol (2000) 1.00
Gene expression of differentiation- and dedifferentiation markers in normal and malignant human thyroid tissues. Exp Clin Endocrinol (1992) 1.00
Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol (1991) 1.00
Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas. J Clin Endocrinol Metab (1995) 1.00
Advances in the management of hereditary medullary thyroid cancer. J Intern Med (2005) 1.00
Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis. Cancer (2000) 0.99
Control of breathing in patients with severe hypothyroidism. Am J Med (1993) 0.99
Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study. Arthritis Rheum (2000) 0.99